from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1866/-

LFCtreatmentdescriptionclass of inhibitor

-0.695

Amikacinug/mL Amikacintranslation

0.950

Cap5-10ug/mL Capreomycintranslation

-0.069

Rox10-50 ug/mL Roxithromycintranslation

1.229

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.356

Rif0.2-5ug/mL Rifampicintranscription

0.310

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.799

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.613

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.652

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.320

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.459

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.081

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.270

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.064

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.081

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.509

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.163

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.998

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.228

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.080

Nigericin50 uM Nigericinrespiration

0.225

TRC10-150 ug/mL Triclosanrespiration

-1.009

TRZ10-25 ug/mL Thioridazinerespiration

-1.034

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.136

menadione6-10 ug/mL Menadionerespiration

0.358

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.585

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.042

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.423

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.320

NRP_1Non-replicating persistence stage 1dosRassociated

-0.181

Amp0.2mg/mL AmpicillincellWall

-0.084

Cephalexin20-100 ug/mL CephalexincellWall

0.871

Cerulenin0.32-5 ug/mL CerulenincellWall

0.614

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.187

EMB10-20 ug/mL EthambutolcellWall

1.274

Eta12-40 ug/mL EthionamidecellWall

-0.229

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.283

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.922

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.045

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.017

BZA0.12 mg/mL BenzamidearomaticAmides

0.704

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.459

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.330

H2O24 mM hydrogen peroxideDNAdamaging

0.010

Levo10 ug/mL LevofloxacinDNAdamaging

0.599

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.562

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.217

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.588

UVUV-irradiationDNAdamaging

-0.768

ARP41-4 ug/mL Antitubercular compound ARP4?

0.406

Antimycin12.5-50 ug/mL Antimycin A?

-0.288

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.282

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.269

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.656

PA8240.2-2 ug/mL PA-824?

-0.777

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.026

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.175

Verapamil50 uM Verapamil?

-0.295

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.478

methoxatin10-20 ug/mL Methoxatin?